DMI Life Sciences
Greenwood Village · Founded 2009
About DMI Life Sciences
DMI Life Sciences, Inc. is a biotechnology company. It discovers and develops small molecule and peptide-based pharmaceuticals and biomarkers for acute and chronic inflammation. The company is focused on immunologic, vascular and CNS diseases, including acute coronary syndrome, multiple sclerosis, Alzheimer’s disease, asthma, and cancer. DMI Life Sciences, Inc. was founded by David Bar and Michael Macaluso in 2009; and is headquartered in Greenwood Village, Colorado.
Company Facts
- Founded: 2009
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $1.2M
- Last round: Series Unknown (Apr 2009)
Industries & Categories
Biotechnology, Life Science, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/dmi-life-sciences-2833423 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.